Phillip Palmbos, MD, PhD, discusses the utilization of adjuvant nivolumab following cystectomy in high-risk, muscle-invasive bladder cancer.
Phillip Palmbos, MD, PhD
Advertisement
Articles by Phillip Palmbos, MD, PhD
Phillip L. Palmbos, MD, PhD, discusses remaining questions in metastatic urothelial carcinoma.
Phillip Palmbos, MD, PhD, discusses the role of chemoimmunotherapy in patients with bladder cancer.
Phillip Palmbos, MD, PhD, discusses updates and therapeutic recommendations for the frontline treatment of patients with bladder cancer.
Advertisement
Latest Updated Articles
Dr. Palmbos on the Utilization of Nivolumab Following Cystectomy in Muscle-Invasive Bladder CancerPublished: February 16th 2022 | Updated:
Dr. Palmbos on Remaining Questions in Metastatic Urothelial CarcinomaPublished: November 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5